The histological discrimination of granulomatous cutaneous T-cell lymphomas (CTCLs) from reactive granulomatous disorders such as sarcoidosis and granuloma annulare (GA) may be difficult due to overlapping histological features. We analyzed the T-cell receptor gene rearrangement in sarcoidosis and GA to investigate the value of the detection of clonal T cells as an adjunctive diagnostic marker in the differentiation between sarcoidosis and GA versus granulomatous CTCLs. Rearrangement of T-cell receptor g genes was examined by the use of automated high-resolution polymerase chain reaction fragment analysis in 35 cases of sarcoidosis and 15 cases of GA and compared with a series of 19 cases of granulomatous CTCLs. A monoclonal T-cell population was found in none of the cases of sarcoidosis and in 2 of 15 cases of GA (13%). In granulomatous CTCLs, a neoplastic T-cell clone was detected in 94%. Presence of clonal T cells argues in favour of a granulomatous CTCL, while a polyclonal T-cell population makes the presence of a sarcoidosis or a GA more likely. The analysis of T-cell clonality is a useful diagnostic adjunct in the differentiation between sarcoidosis and GA from granulomatous CTCLs.
INTRODUCTION
Granulomatous features are a rare finding in primary cutaneous lymphomas (CLs), occurring in approximately 2% of all CLs. 1, 2 The most common forms of cutaneous T-cell lymphoma (CTCL) displaying granulomatous features are granulomatous mycosis fungoides (MF) and granulomatous slack skin (GSS). Both entities show overlapping histological features but differ in their clinical presentation. 3 GSS is characterized by the formation of bulky skin folds. [2] [3] [4] Histologically, granulomas in CTCLs, particularly granulomatous MF, most commonly present with a sarcoid-like or a granuloma anulare-like pattern, but tuberculoid granulomas have been described as well. [1] [2] [3] [5] [6] [7] The presence of a prominent granulomatous infiltrate in granulomatous CTCL may render the diagnosis challenging and may eventually result in a misdiagnosis of an inflammatory skin disease. 3 Although the presence of clonal T cells is not restricted to CTCL and therefore does per se not prove a CTCL, detection of clonal T-cells by molecular assays represents an important adjunctive diagnostic marker for the diagnosis of CTCL. 8, 9 Clonal T cells are found in up to 90% of MF in its plaque stage and are also a consistent feature in other forms of CTCLs. 10, 11 In granulomatous MF, the neoplastic lymphocytes are masqueraded by the prominent granulomatous component. Moreover, granulomatous MF often lacks other important diagnostic features of MF such as epidermotropism and nuclear atypia of lymphocytes rendering differentiation from granulomatous inflammatory diseases such as sarcoidosis or granuloma annulare (GA) difficult. 3 We examined a series of sarcoidosis and GA by polymerase chain reaction (PCR) to investigate whether the detection of a clonal T-cell population is of value as an adjunctive diagnostic marker in the differentiation between these granulomatous inflammatory disorders versus granulomatous MF. The results were compared with the previously reported frequency of monoclonal rearrangement of T-cell receptor gamma genes in cases of granulomatous CTCLs.
MATERIALS AND METHODS
Thirty-five cases of sarcoidosis and 15 cases of GA with a significant number of admixed lymphocytes were selected from the archives of the laboratory Kempf and Pfaltz, Histological Diagnostics, Zürich, and the Unit of Dermatopathology, Department of Dermatology of the University Hospital Zürich, diagnosed between 2005 and 2010 and compared with a group of 19 cases of granulomatous CTCLs, which had been analyzed in the context of an international multicenter study on granulomatous MF by the European Organization for Research and Treatment (EORTC) Cutaneous Lymphoma Task Force. 3 For all cases of sarcoidosis and GA and granulomatous CTCL, diagnosis had been established by clinicopathological correlation. A followup of at least 1 year was required for inclusion. The 35 cases of sarcoidosis included 1 case of scar sarcoidosis, 5 cases of lupus pernio, and 1 case of sarcoid-like foreign body reaction.
Rearrangement of T-cell receptor g genes was assessed by automated high-resolution PCR fragment analysis analyzing rearrangement of the TCR gamma-chain genes. 12 For DNA isolation, 4-10, 10-micrometer paraffin sections were deparaffinized with xylene and ethanol and digested with 0.6 mg proteinase K overnight. DNA was purified by the QIAamp DNA Mini Kit (QIAGEN, Hilden, Germany) and extracted with 150-mL elution buffer. DNA integrity was confirmed by PCR for the factor V gene. Clonality analysis was performed with three multiplex PCRs with different primers from the variable region in each reaction (reaction 1; Vg1-8, reaction 2; Vg9, and reaction 3: Vg10, Vg11, and Vg12) and the same Cy-5-labeled primers from the conserved region (JGP1/2, JG1/2, and JGP). The control PCR was performed with 80 mM primers, multiplex PCR with 20 mM primer each. All reactions were run under the same conditions with 1.5 mM MgCl2, 50 mM KCl, 10 mM Tris-HCl (pH9.0), 200 mM deoxyribonucleoside triphosphates (dNTPs) each, and 1.5 U of Taq-Polymerase in a final volume of 25 mL. PCR conditions were as follows: 20 seconds at 94°C, 20 seconds at 62°C in reaction 1 (56°C in reactions 2 and 3), and 20 seconds at 72°C, 35 cycles. After denaturation for 2.5 minutes at 85°C, all samples were loaded on a denaturing gel (ReproGel high resolution, Amersham Biosciences, Piscataway, NJ) and run at 55°C and 30 W for 200 minutes. Visualization of the fluorescentlabeled PCR products was performed by a fragment analysis software (Fragment analyzer, Amersham Biosciences) connected to a laser-based automated sequencer (AlfExpress II, Amersham Biosciences). DNA from a biopsy of a patient with a cutaneous T-cell lymphoma was used as positive control; a PCR mix without DNA was used as negative control. Reactions in positive cases were repeated in duplicate. Presence of amplifiable DNA extracted from the formalin-fixed and paraffin-embedded tissue was checked by amplification of factor V-specific sequences.
For statistical analysis, x 2 test was used to evaluate significance of differences between the detection rates of clonality in granulomatous inflammatory disorders (sarcoidosis, GA) and the series of granulomatous CTCL of the EORTC study.
The study was approved by the ethics review board of the Canton Zurich, Switzerland.
RESULTS
Successful amplification of DNA was obtained in all cases. Monoclonal rearrangement of the TCR-gamma genes was demonstrated in 2 of 15 cases (13%) of GA but was not found in any of the 35 cases of sarcoidosis (Table 1) . Pseudoclonality was excluded by repeating clonality analysis in duplicate. Histology of the 2 GA cases showed characteristic features with necrobiotic areas in the upper and middermis surrounded by a histiocytic infiltrate (Fig. 1) . The lymphocytes were small and did not display nuclear atypia. On immunohistochemistry, the lymphocytes corresponded to CD3 + CD4 + lymphocytes. Clinically, 1 of the 2 patients (56year-old woman; case no 42) presented with annular lesions on the left breast and right thigh. Serological examinations for borrelia sp. were negative. Follow-up after 3 years revealed complete remission, which had been taken place after several months without treatment. The second patient (65-year-old woman; case no 50) showed a papular lesion on the back of the fourth finger of the right hand. During follow-up of 1 year, a second annular lesion occurred within the same area of the In granulomatous MF and GSS, a neoplastic T-cell clone had been detected by PCR in 13 of 14 cases of granulomatous MF and in all 4 cases of GSS resulting in a detection rate of 94% for monoclonal rearrangement of TCR gamma genes in granulomatous CTCL. 3 One case of granulomatous MF (no 52) could not be analyzed because only very sparse tissue was left on the paraffin block so that not a sufficient amount of DNA could be extracted.
Statistical analysis revealed significant difference of the detection rate between the total group of granulomatous inflammatory disorders (sarcoidosis and GA; x 2 = 53.8, df = 1, P , 0.0001), but also for each disease when compared with the series of granulomatous CTCL (sarcoidosis vs. granulomatous CTCL: x 2 = 48.7, df = 1, P , 0.0001; GA vs. granulomatous CTCL: x 2 = 20.0, df = 1, P , 0.0001).
DISCUSSION
Granuloma formation was reported in a variety of primary CTCLs including MF, Sézary syndrome, primary cutaneous anaplastic large T-cell lymphoma, adult T-cell lymphoma, and primary cutaneous small to medium-sized (pleomorphic) T-cell lymphoma. 2, 3, [13] [14] [15] The differentiation of granulomatous CTCLs, however, from reactive granulomatous disorders such as sarcoidosis or GA may be difficult mainly because the neoplastic lymphocytes are masqueraded by the granuloma formation. Therefore, diagnosis of granulomatous MF is established in many cases with a delay of several months or years. 3 Sarcoidosis is histologically characterized by a dermal infiltrate of typically naked sarcoid granulomas, composed of aggregates of epitheloid cells without a significant number of admixed other inflammatory cells. However, granulomas with a significant number of lymphocytes can be found in approximately 29% of the cases. 16 There are no definite immunohistochemical differences between T lymphocytes in sarcoidosis or GA versus T cells in granulomatous MF, as lymphocytes with a CD4 + T helper-cell phenotype predominate in both scenarios. Detection of clonal T cells is found in up to 90% of MF in its plaque stage, but clonal T cells are only rarely found in reactive and inflammatory disorders. 10 Previous studies reported monoclonal T cells in more than 90% cases of granulomatous MF. Scarabello et al 2 reported clonal T cells in 11 of 12 cases (92%) of granulomatous MF. In the multicenter EORTC study, monoclonal rearrangement of TCR gamma genes was detected by PCR in 94% of granulomatous MF and GSS. 3 Denaturing gradient gel electrophoresis-based detection and Gene scan analysis using to the BIOMED 2 protocols are equally sensitive and specific approaches for the assessment of T-cell clonality. 17, 18 Since the series of granulomatous CTCL had been analyzed by denaturing gradient gel electrophoresis-PCR approach, the same method was used for the examination of the cases of sarcoidosis and GA. Data on T-cell clonality in sarcoidosis and GA have not yet been reported. In our series, all 35 cases of sarcoidosis with a significant number of admixed lymphocytes showed polyclonal T cells. In contrast, a subset of GA (2 out of 15 cases; 13%) harbored a clonal T-cell population. The frequency is in accordance with previous data, which reported detection of clonal T cells in a small percentage of benign inflammatory skin diseases. 19 Presence of T-cell clonality in a subset of GA adds this disorder to the group of inflammatory dermatoses, for which detection of clonal T cells in a subset of cases was reported, including lichen planus, pityriasis lichenoides et varioliformis, and pigmented purpuric dermatoses. [20] [21] [22] The presence of clonal T cells in these inflammatory disorders may 23 Diagnosis in granulomatous CTCL is often delayed with a latency of years to decades after onset of first symptoms. In one series of GMF patients, first symptoms had occurred at an average of 10 years before diagnosis. 3 Remarkably, in most cases, granulomatous features were present already at early stages of the disease. An early diagnosis of granulomatous MF is of importance, especially because the prognosis of granulomatous MF with a 5-year-survival of 66% is worse than in classic MF. 3 Patients with granulomatous MF may benefit from early diagnosis by initiating a more intense treatment already at an early stage of the disease. Our results demonstrate that the analysis of a T-cell receptor rearrangement is a useful diagnostic adjunct in the differentiation between sarcoidosis and GA from granulomatous MF. A monoclonal T-cell population argues in favor of a granulomatous CTCL with a sensitivity of 94% and a specificity of 96%. In contrast, a polyclonal T-cell population makes the presence of sarcoidosis or a GA more likely with a negative predictive value of 98%. The detection of clonal T cells in a small subset of GA, however, underlines the importance of clinicopathological correlation to avoid misinterpretation.
